Bryce Pardo

Photo of Bryce Pardo
Associate Policy Researcher
Washington Office

Education

Ph.D., University of Maryland; M.A. in Latin American Studies, George Washington University; B.A. in political science, George Washington University

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email media@rand.org.

More Experts

Overview

Bryce Pardo is an associate policy researcher at the RAND Corporation. His work focuses on drug policy with a particular interest in the areas of cannabis regulation, opioid control, and new psychoactive substance markets. He has over ten years of experience working with national, state, and local governments in crime and drug policy. Prior to joining RAND, he served five years as a legislative and policy analyst at the Inter-American Drug Abuse Control Commission (CICAD) within the Organization of American States (OAS) where he worked directly with policymakers and practitioners. He has independently consulted with multi-lateral institutions, including the Pan-American Health Organization (PAHO) and the United Nations Office on Drugs and Crime (UNODC). Pardo also served as lead analyst with BOTEC Analysis Corporation to support the Government of Jamaica in drafting medical cannabis regulations. Pardo has years of experience in data science (programming in R and STATA), quantitative analysis, econometric modeling, writing descriptive analyses, and literature reviews. He has experience conducting qualitative research, including stakeholder interviews and survey design and analysis. His research and academic works have been published in the International Journal of Drug Policy, Addiction, Lancet Psychology, Criminology and Public Policy, and reports for the London School of Economics, UNODC, PAHO, and the National Academy of Sciences. Pardo holds a Ph.D. in public policy from the University of Maryland, College Park and an M.A. in Latin American studies and a B.A. in political science from the George Washington University.

Selected Publications

Bryce Pardo, Evolution of the U.S. Overdose Crisis: Understanding China's Role in the Production and Supply of Synthetic Opioids, RAND (CT-497), 2018

Bryce Pardo and Peter Reuter, "Narcotics and Drug Abuse: Foreshadowing of 50 Years of Change," Criminology and Public Policy, 17(2), 2018

Bryce Pardo and Peter Reuter, "Facing fentanyl: should the USA consider trialling prescription heroin?" Lancet Psychiatry, 2018

Bryce Pardo, "Do More Robust Prescription Drug Monitoring Programs Reduce Prescription Opioid Overdose?" Addiction, 2017

Steven Davenport and Bryce Pardo, "The Dangerous Drugs Act Amendment in Jamaica: Reviewing Goals, Implementation, and Challenges," International Journal of Drug Policy, 2016

Peter Reuter and Bryce Pardo, "New psychoactive substances: Are there any good options for regulating New Psychoactive Substances?" International Journal of Drug Policy, 2016

Peter Reuter and Bryce Pardo, "Can New Psychoactive Substances Be Regulated Effectively? An Assessment of the British Psychoactive Substances Bill.," Addiction, 2016

Bryce Pardo, "Cannabis Policy Reforms in the Americas: A Comparative Analysis of Colorado, Washington, and Uruguay.," International Journal of Drug Policy, 2014

Languages

Spanish; Portuguese

Commentary

  • Tackle Fentanyl like a Poisoning Outbreak, Not a Drug Epidemic

    America's fentanyl problem is far deadlier than past crises with other illegal drugs. New ideas, be they public policies, technologies or law enforcement strategies, are desperately needed. Continuing to treat fentanyl just like previous drug epidemics will likely be insufficient and may condemn thousands more to early deaths.

    Sep 3, 2019 Los Angeles Times

  • Bags of fentanyl at the U.S. Customs and Border Protection area at the International Mail Facility at O'Hare International Airport in Chicago, Illinois, November 29, 2017, photo by Joshua Lott/Reuters

    China's Ban on Fentanyl Drugs Won't Likely Stem America's Opioid Crisis

    Given China's recent decision to ban the unauthorized manufacture of fentanyl, authorities there appear to recognize a growing problem. But China cannot solve the U.S. opioid problem. The United States could do more to reduce demand for opioids as well as drug users' exposure to these powerful drugs.

    May 22, 2019 Los Angeles Times

  • A supervised injection site for people who use drugs, in Lausanne, Switzerland, September 28, 2018, photo by Denis Balibouse/Reuters

    Addressing Federal Conflicts Over Supervised Drug Consumption Sites

    With drug overdose deaths mounting, some American cities are trying to create designated spaces where people who use heroin and other drugs can have their consumption supervised by medical professionals. The Department of Justice argues these sites would violate federal law, but federal decisionmakers have several options.

    Mar 14, 2019 The Hill

Publications